Product image of Linezolid Accord (Linezolid) supplied by GNH India

Linezolid Accord

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Accord (Linezolid)

Linezolid, the active ingredient in Linezolid Accord, is an oxazolidinone antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients. It is often reserved for complicated skin and soft‑tissue infections, pneumonia, and bloodstream infections where other agents may be ineffective.

GNH India supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourced from the European Union market with full regulatory compliance.

Manufacturer / TM Owner

Accord Healthcare S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid Accord is used to treat infections caused by susceptible Gram‑positive bacteria, particularly in the skin, respiratory and bloodstream compartments.

  • Skin and soft‑tissue infections: eradicates MRSA and other susceptible organisms, leading to clinical cure and resolution of lesions.
  • Community‑acquired bacterial pneumonia: provides bacteriostatic activity against Streptococcus pneumoniae and MRSA, improving pulmonary outcomes.
  • Hospital‑acquired or ventilator‑associated pneumonia: targets resistant Gram‑positive pathogens, facilitating recovery and reducing mortality risk.
  • Infections caused by vancomycin‑resistant Enterococcus (VRE): suppresses bacterial protein synthesis, allowing control of otherwise limited‑treatment infections.

How It Works

  • Linezolid binds to the 50S subunit of bacterial ribosomes, preventing the formation of the initiation complex required for protein synthesis. This inhibition halts bacterial growth by blocking translation of essential proteins, resulting in a bacteriostatic effect against susceptible Gram‑positive organisms, including MRSA and VRE.

Side Effects

Linezolid Accord may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: transient dysgeusia.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Anemia: reduction in hemoglobin levels.
  • Peripheral neuropathy: sensory disturbances with prolonged use.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: rare metabolic disturbance.
  • Optic neuritis: vision changes necessitating ophthalmic evaluation.

Precautions & Warnings

When prescribing Linezolid Accord, clinicians should consider several safety aspects.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid due to risk of serotonin syndrome.
  • Myelosuppression risk: perform routine complete blood counts.
  • Hypersensitivity: discontinue immediately if allergic reaction occurs.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Linezolid Accord interacts with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): heightened serotonin toxicity.
  • Rifampin: significant reduction in linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential increase in INR, monitor coagulation.
  • Cytochrome P450 substrates: possible alteration of metabolism, observe therapeutic levels.
  • Antacids containing magnesium or aluminum: may affect absorption, separate dosing times.

Frequently Asked Questions

Linezolid Accord is an oral oxazolidinone antibiotic indicated for the treatment of infections caused by susceptible Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE). It is commonly prescribed for skin and soft‑tissue infections, community‑acquired and hospital‑acquired pneumonia, and other serious Gram‑positive infections where alternative agents may be ineffective.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. This binding prevents the formation of the initiation complex needed for translation, resulting in a bacteriostatic effect that stops the growth of susceptible Gram‑positive organisms such as MRSA and VRE.

The dosage of Linezolid Accord is determined by the prescribing healthcare professional based on the specific infection, patient characteristics, and local guidelines. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for linezolid during pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit outweighs the potential risk to the fetus or infant. Healthcare providers should evaluate each case individually and discuss possible risks with the patient.

To order Linezolid Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The primary alternative to linezolid for Gram‑positive infections is vancomycin, a glycopeptide antibiotic administered intravenously. Linezolid offers the advantage of oral administration, good tissue penetration, and activity against some vancomycin‑resistant strains. However, vancomycin may be preferred for certain severe infections or when linezolid’s hematologic toxicity risk is a concern.

Linezolid Accord should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

Linezolid Accord is administered orally, typically as a tablet taken with or without food. Patients should swallow the tablet whole with water and follow the prescriber’s dosing schedule. Consistency in timing helps maintain stable drug levels.

Serious risks include thrombocytopenia, anemia, peripheral neuropathy, and serotonin syndrome, especially when combined with serotonergic medications. Patients should be monitored for signs of bleeding, unexplained fatigue, neuropathic symptoms, or changes in mental status, and report any concerning symptoms to their healthcare provider promptly.

Linezolid Accord should not be used by individuals with known hypersensitivity to linezolid or any component of the formulation. It is also contraindicated in patients currently receiving monoamine oxidase inhibitors or other serotonergic agents due to the risk of serotonin syndrome, and caution is advised in those with severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.